KM Investigating Class Action Against Valeant Pharmaceuticals International, Inc.
October 22, 2015
The class action department of Koskie Minsky LLP today announced that it is investigating a potential class action on behalf of Valeant’s shareholders concerning alleged misrepresentations in Valeant Pharmaceuticals International, Inc.’s public disclosure.
On October 21, 2015, the short seller Citron Research issued a report alleging that Valeant Pharmaceuticals International Inc. has failed to disclose the creation of a network of pharmacies that were set up for the purpose of creating fraudulent invoices to deceive its auditors and improperly record revenue. Upon the release of Citron Research’s report, Valeant’s share price on the TSX dropped dramatically.
Persons who owned Valeant’s securities are encouraged to contact Garth Myers at Koskie Minsky LLP by telephone at (416) 595-2102 or by email at firstname.lastname@example.org.
Koskie Minsky LLP, based in Toronto, is one of Canada’s foremost class action, labour, employment and litigation firms. Its class actions group has been a national leader in class actions and has prosecuted many of the leading cases in the area.
Jonathan Ptak, (416) 595-2149
Garth Myers, (416) 595-2102